Therapeutic Targeting of the Cyclin D3:CDK4/6 Complex in T Cell Leukemia-Reference-Cited by-同舟云学术

Therapeutic Targeting of the Cyclin D3:CDK4/6 Complex in T Cell Leukemia

Published:2012-10 Issue:4 Volume:22 Page:452-465
ISSN:1535-6108
Container-title:Cancer Cell
language:en
Short-container-title:Cancer Cell

Author:

Sawai Catherine M.,Freund Jacquelyn,Oh Philmo,Ndiaye-Lobry Delphine,Bretz Jamieson C.,Strikoudis Alexandros,Genesca Lali,Trimarchi Thomas,Kelliher Michelle A.,Clark Marcus,Soulier Jean,Chen-Kiang Selina,Aifantis Iannis

Publisher

Elsevier BV

Subject

Cancer Research,Cell Biology,Oncology

Reference48 articles.

1. Molecular pathogenesis of T-cell leukaemia and lymphoma;Aifantis;Nat. Rev. Immunol.,2008

2. Multiple functions of D-type cyclins can antagonize pRb-mediated suppression of proliferation;Baker;Cell Cycle,2005

3. A novel orally active small molecule potently induces G1 arrest in primary myeloma cells and prevents tumor growth by specific inhibition of cyclin-dependent kinase 4/6;Baughn;Cancer Res.,2006

4. Cyclin D dysregulation: an early and unifying pathogenic event in multiple myeloma;Bergsagel;Blood,2005

5. Genetic replacement of cyclin D1 function in mouse development by cyclin D2;Carthon;Mol. Cell. Biol.,2005

Cited by 154 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lineage-specific proteome remodeling of diverse lung cancer cells by targeted epigenetic inhibitors;2024-05-28

2. Unveiling novel therapeutic avenues: Targeting the cyclin D/CDK4 axis for enhanced cancer treatment;Medical Hypotheses;2024-04

3. In vivo senescence imaging nanoprobe targets the associated reactive oxygen species;Nanoscale;2024

4. Preclinical evaluation of the third-generation, bi-steric mechanistic target of rapamycin complex 1-selective inhibitor RMC-6272 in NF2-deficient models;Neuro-Oncology Advances;2024-01-01

5. CDK6: an attractive therapeutic target for T-ALL/LBL;Expert Opinion on Therapeutic Targets;2023-11-02